Greykasell Wealth Strategies, Inc. Teva Pharmaceutical Industries LTD Transaction History
Greykasell Wealth Strategies, Inc.
- $187 Billion
- Q1 2025
A detailed history of Greykasell Wealth Strategies, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Greykasell Wealth Strategies, Inc. holds 700 shares of TEVA stock, worth $11,746. This represents 0.01% of its overall portfolio holdings.
Number of Shares
700Holding current value
$11,746% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
660Shares Held
627MCall Options Held
27.9MPut Options Held
21.8M-
Black Rock Inc. New York, NY43MShares$721 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E939MShares$655 Million39.53% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$634 Million5.98% of portfolio
-
Menora Mivtachim Holdings Ltd.29.2MShares$490 Million2.92% of portfolio
-
Exor Capital LLP London, X027.9MShares$467 Million12.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.6B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...